Filing Details
- Accession Number:
- 0001209191-23-033391
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-01 17:41:52
- Reporting Period:
- 2023-05-30
- Accepted Time:
- 2023-06-01 17:41:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1601830 | Recursion Pharmaceuticals Inc. | RXRX | Biological Products, (No Disgnostic Substances) (2836) | 464099738 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1856094 | Blake Borgeson | C/O Recursion Pharmaceuticals 41 S. Rio Grande Street Salt Lake City UT 84101 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2023-05-30 | 8,885 | $8.79 | 7,540,747 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sales are pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 9, 2022.
- The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $8.47 to $9.57 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
Billionaire Hedge Funds
